Last reviewed · How we verify
NCT05011799
The Peer Genetic Study
NA trial testing Cancer Educational Materials in Healthy Subject in 149 participants. Completed in 28 September 2024.
30 June 2023
Quick facts
| Lead sponsor | Thomas Jefferson University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 149 |
| Start date | 8 January 2020 |
| Primary completion | 30 June 2023 |
| Estimated completion | 28 September 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cancer Educational Materials
- Questionnaire Administration
- Educational Intervention
Conditions studied
- Healthy Subject — all drugs for Healthy Subject →
- Prostate Carcinoma — all drugs for Prostate Carcinoma →
Sponsor
Thomas Jefferson University
Who can join
Adults 35 to 69, male only, with Healthy Subject or Prostate Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial studies how well a peer-based health education program works in reducing barriers and changing attitudes and beliefs of prostate cancer genetic screening in African American participants with or without a previous personal or family history of prostate cancer. Participating in a peer-based health educational program may help participants learn more about prostate cancer and how their personal or family history of disease may increase their risk of prostate cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
Kaushal JB, Raut P, Muniyan S, Siddiqui JA, et al · · 2024 · cited 4× · PMID 38902476 · DOI 10.1007/s10555-024-10193-8
Verify or expand the search:
- PubMed search for NCT05011799
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cancer Educational Materials
Trials testing the same drug.
- NCT04496739 — Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) · NA · active not recruiting
- NCT03929926 — Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients · NA · completed
- NCT03943082 — Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials · NA · terminated
Other recruiting trials for Healthy Subject
Currently open trials in the same condition.
- NCT03897270 — Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects · NA · recruiting
- NCT03303846 — Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients · NA · active not recruiting
- NCT03491176 — Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer · active not recruiting
- NCT03207854 — Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers · recruiting
- NCT03199365 — Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families · NA · active not recruiting
Other Thomas Jefferson University trials
Trials by the same sponsor.
- NCT07526480 — Improving Dementia Care in Primary Practice · NA · not yet recruiting
- NCT07414550 — Radiotherapy for Refractory Hidradenitis Suppurativa · NA · not yet recruiting
- NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
- NCT07217197 — Respiratory Monitoring System That Detects & Predicts OIRD · NA · enrolling by invitation
- NCT07145099 — The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05011799 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thomas Jefferson University
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05011799.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing